Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial
Background This study evaluated the pharmacokinetics of dolutegravir in HIV-infected [...]
EMPIRICAL Project’s 5th Annual Meeting Highlights Major Milestones and Future Plans
The 5th Annual Meeting of the EMPIRICAL Project was held [...]
Journal of the Pediatric Infectious Diseases Society BRIEF REPORT
First-Line Antituberculosis Drug Concentrations in Infants With HIV and a [...]
Clinical Infectious Diseases MAJOR ARTICLE
Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A [...]
Nota de Prensa Hospital 12 de Octubre
La Unidad de Enfermedades Infecciosas aporta por primera vez información [...]
